The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...

The Pentagon says the military services must again ask troops who were forced out or who voluntarily left the military due to ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Louisiana’s surgeon general said in a memo Thursday that the state would “encourage each patient to discuss the risks and benefits of vaccination with their provider” but would “no longer promote mass ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

The doctor beamed onto a health clinic video screen in October to convince the regional health board to ban public clinics in ...